Abstract
Gene therapy can prevent or cure diverse pathological conditions associated with defects in gene expression. Three main delivery systems used to deliver genes to target cells include mechanical, biological, and chemical method of DNA transfection. However viral vectors were the most studied and reported; associated side effects and limitations of viral vectors (high risk of mutagenicity, immunogenicity, low production yield, limited gene-loading capacity, and poor host range) have led to the development of nonviral vectors. On the light of the above background, cationic lipids may be alternatively used as promising carriers for nucleic acid delivery. With certain advantages over viral vectors, such as low immunogenicity, high loading capacity, broad range of host cell, being cheap, and easy reproduction, cationic lipid will be the choice for future gene delivery system. This chapter provides an overview of recent developments employed for in vitro and in vivo delivery of therapeutically important nucleic acids using different types of cationic lipids.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Almeida MLS, Grehn L, Ragnarsson U (1988) Selective protection of polyamines: synthesis of model compounds and spermidine derivatives. J Chem Soc Perkin Trans 1(7):1905–1911
Balazs DA, Godbey WT (2011) Liposomes for use in gene delivery. J Drug Deliv 2011:1–12
Behr JP (1986) DNA strongly binds to micelles and vesicles containing lipopolyamines or lipointercalants. Tetrahedron Lett 27(48):5861–5864
Bennett CF, Chiang MY, Chan H et al (1992) Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 41(6):1023
Crook K, Stevenson BJ, Dubouchet M et al (1998) Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum. Gene Ther 5(1):137–143
Darquet AM, Rangara R, Kreiss P et al (1999) Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer. Gene Ther 6(2):209–218
Das J, Han JW, Choi YJ et al (2016) Cationic lipid-nanoceria hybrids, a novel nonviral vector-mediated gene delivery into mammalian cells: investigation of the cellular uptake mechanism. Sci Rep 6(1):29197
Duzgunes N, Goldstein JA, Friend DS et al (1989) Fusion of liposomes containing a novel cationic lipid, N-[2,3-(dioleyloxy)propyl]-N,N,N-trimethylammonium: induction by multivalent anions and asymmetric fusion with acidic phospholipid vesicles. Biochemistry 28(23):9179–9184
Edelstein ML, Abedi MR, Wixon J (2004) Gene therapy clinical trials worldwide 1989-2004—an overview. J Gene Med 6(6):597–602
Even-Chen S, Barenholz Y (2000) DOTAP cationic liposomes prefer relaxed over supercoiled plasmids. Biochim Biophys Acta 1509(1):176–188
Felgner PL, Gadek TR, Holm M et al (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 84(21):7413–7417
Friend DS, Papahadjopoulos D, Debs RJ (1996) Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. Biochim Biophys Acta 1278(1):41–50
Galanis E, Hersh EM, Stopeck AT et al (1999) Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience. J Clin Oncol 17(10):3313–3323
Ginn SL, Amaya AK, Alexander IE et al (2018) Gene therapy clinical trials worldwide to 2017: an update. J Gene Med 20(5):e3015
Guo X, Huang L (2012) Recent advances in nonviral vectors for gene delivery. Acc Chem Res 45(7):971–979
Hoffman DMJ, Figlin RA (2000) Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complex. World J Urol 18(2):152–156
Hofland HE, Shephard L, Sullivan SM (1996) Formation of stable cationic lipid/DNA complexes for gene transfer. Proc Natl Acad Sci 93(14):7305
Hofland HEJ, Nagy D, Liu JJ et al (1997) In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex. Pharm Res 14(6):742–749
Hong YS, Laks H, Cui G et al (2002) Localized immunosuppression in the cardiac allograft induced by a new liposome-mediated IL-10 gene therapy. J Heart Lung Transplant 21(11):1188–1200
In KH, Asano K, Beier D et al (1997) Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 99(5):1130–1137
Jensen DK, Jensen LB, Koocheki S et al (2012) Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA. J Control Release 157(1):141–148
Jinturkar KA, Rathi MN, Misra A (2011) Gene delivery using physical methods. In: Misra A (ed) Challenges in delivery of therapeutic genomics and proteomics. Elsevier, London, pp 83–126
Kamihira M, Nishijima KI, Iijima S (2004) Transgenic birds for the production of recombinant proteins. In: Kobayashi T (ed) Recent progress of biochemical and biomedical engineering in Japan II. Springer, Berlin, pp 171–189
Kawakami S, Harada A, Sakanaka K et al (2004) In vivo gene transfection via intravitreal injection of cationic liposome/plasmid DNA complexes in rabbits. Int J Pharm 278(2):255–262
Kreiss P, Mailhe P, Scherman D et al (1999) Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res 27(19):3792–3798
Kumar D (2020) The human genome and molecular medicine. In: Kumar D (ed) Clinical molecular medicine. Academic Press, London, pp 3–16
Kunitake T, Okahata Y, Tamaki K, Kumamaru F, Takayanagi M (1977) Formation of the bilayer membrane from a series of quaternary ammonium salts. Chem Lett 6(4):387–390
Lalani J, Misra A (2011) Gene delivery using chemical methods. In: Misra A (ed) Challenges in delivery of therapeutic genomics and proteomics. Elsevier, London, pp 127–206
Lampela P, Räisänen J, Männistö PT et al (2002) The use of low-molecular-weight PEIs as gene carriers in the monkey fibroblastoma and rabbit smooth muscle cell cultures. J Gene Med 4(2):205–214
Lampela P, Elomaa M, Ruponen M et al (2003) Different synergistic roles of small polyethylenimine and Dosper in gene delivery. J Control Release 88(1):173–183
Lehn JM, Lehn P, Vigneron JP (2000) Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof. US Patent 6143729, 7 Nov 2011
Liu F, Qi H, Huang L et al (1997) Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther 4(6):517–523
Luton D, Oudrhiri N, de Lagausie P et al (2004) Gene transfection into fetal sheep airways in utero using guanidinium-cholesterol cationic lipids. J Gene Med 6(3):328–336
Malone RW, Felgner PL, Verma IM (1989) Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci 86(16):6077
Margineanu DG (1987) Equilibrium and non-equilibrium approaches in biomembrane thermodynamics. Arch Physiol Biochem 95(4):381–422
Marshall E (1999) Gene therapy death prompts review of adenovirus vector. Science 286(5448):2244–2245
Mashal M, Attia N, Puras G et al (2017) Retinal gene delivery enhancement by lycopene incorporation into cationic niosomes based on DOTMA and polysorbate 60. J Control Release 254:55–64
Matsumoto M, Kishikawa R, Kurosaki T et al (2008) Hybrid vector including polyethylenimine and cationic lipid, DOTMA, for gene delivery. Int J Pharm 363(1):58–65
McCluskie MJ, Chu Y, Xia JL et al (1998) Direct gene transfer to the respiratory tract of mice with pure plasmid and lipid-formulated DNA. Antisense Nucleic Acid Drug Dev 8(5):401–414
Merlin JL, Dolivet G, Dubessy C et al (2001) Improvement of nonviral p53 gene transfer in human carcinoma cells using glucosylated polyethylenimine derivatives. Cancer Gene Ther 8(3):203–210
Mizuarai S, Ono KI, You J et al (2001) Protamine-modified DDAB lipid vesicles promote gene transfer in the presence of Serum1. J Biochem 129(1):125–132
Moret I, Esteban Peris J, Guillem VM et al (2001) Stability of PEI–DNA and DOTAP–DNA complexes: effect of alkaline pH, heparin and serum. J Control Release 76(1):169–181
Norman JA, Hobart P, Manthorpe M et al (1997) Development of improved vectors for DNA-based immunization and other gene therapy applications. Vaccine 15(8):801–803
Ohama Y, Heike Y, Sugahara T et al (2005) Gene transfection into HeLa cells by vesicles containing cationic peptide lipid. Biosci Biotechnol Biochem 69(8):1453–1458
Ott G, Singh M, Kazzaz J et al (2002) A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines. J Control Release 79(1–3):1–5
Pitard B, Oudrhiri N, Vigneron JP et al (1999) Structural characteristics of supramolecular assemblies formed by guanidinium-cholesterol reagents for gene transfection. Proc Natl Acad Sci 96(6):2621
Porteous DJ, Dorin JR, McLachlan G et al (1997) Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther 4(3):210–218
Pun SH, Hoffman AS (2013) B.8 - Nucleic acid delivery. In: Ratner BD, Hoffman AS, Schoen FJ et al (eds) Biomaterials science, 3rd edn. Academic Press, Waltham, MA, pp 1047–1054
Regelin AE, Fankhaenel S, Gürtesch L et al (2000) Biophysical and lipofection studies of DOTAP analogs. Biochim Biophys Acta 1464(1):151–164
Remaut K, Sanders NN, Fayazpour F et al (2006) Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes. J Control Release 115(3):335–343
Ren T, Song YK, Zhang G et al (2000) Structural basis of DOTMA for its high intravenous transfection activity in mouse. Gene Ther 7(9):764–768
Rose JK, Buonocore L, Whitt MA (1991) A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. BioTechniques 10(4):520–525
Rosenberg SA, Spiess P, Lafreniere RJS (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233(4770):1318–1321
Saijo Y, Perlaky L, Wang H et al (1994) Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice. Oncol Res 6(6):243–249
Sakurai F, Nishioka T, Saito H et al (2001) Interaction between DNA–cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid. Gene Ther 8(9):677–686
Schäfer J, Höbel S, Bakowsky U et al (2010) Liposome–polyethylenimine complexes for enhanced DNA and siRNA delivery. Biomaterials 31(26):6892–6900
S̆misterová J, Wagenaar A, Stuart MC et al (2001) Molecular shape of the cationic lipid controls the structure of cationic lipid/dioleylphosphatidylethanolamine-DNA complexes and the efficiency of gene delivery. J Biol Chem 276(50):47615–47622
Souza S, Rosseels V, Denis O et al (2002) Improved tuberculosis DNA vaccines by formulation in cationic lipids. Infect Immun 70(7):3681–3688
Stephan DJ, Yang ZY, San H et al (1996) A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther 7(15):1803–1812
Templeton NS, Lasic DD, Frederik PM et al (1997) Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 15(7):647–652
Todd R, McBride J, Tsujl T et al (1995) Deleted in oral cancer-1 (doc-l), a novel oral tumor suppressor gene. FASEB J 9(13):1362–1370
Tsukamoto H, Boado RJ, Pardridge WM (1997) Site-directed deletion of a 10-nucleotide domain of the 3′-untranslated region of the GLUT1 glucose transporter mRNA eliminates cytosolic protein binding in human brain tumors and induction of reporter gene expression. J Neurochem 68(6):2587–2592
Vigneron JP, Oudrhiri N, Fauquet M et al (1996) Guanidinium-cholesterol cationic lipids: efficient vectors for the transfection of eukaryotic cells. Proc Natl Acad Sci 93(18):9682
Wheeler CJ (2013) Complex cationic lipids having quaternary nitrogens therein. US Patent 8,541,628, 24 Sept 2013
Wheeler CJ, Felgner PL, Tsai YJ et al (1996) A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc Natl Acad Sci 93(21):11454
Wollenberg B, Kastenbauer D, Mundl H et al (1999) Gene therapy—phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II-IV with a single intratumoral injection of hIL-2 plasmids formulated in DOTMA/Chol. Hum Gene Ther 10(1):141–147
Zhi D, Zhang S, Cui S et al (2013) The headgroup evolution of cationic lipids for gene delivery. Bioconjug Chem 24(4):487–519
Zhu L, Mahato RI (2010) Lipid and polymeric carrier-mediated nucleic acid delivery. Expert Opin Drug Deliv 7(10):1209–1226
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kardani, S., Vaishnav, D. (2021). Potential Applications of Cationic Lipids in Nucleic Acid-Based Therapeutic Delivery System. In: Shah, N. (eds) Nanocarriers: Drug Delivery System. Springer, Singapore. https://doi.org/10.1007/978-981-33-4497-6_13
Download citation
DOI: https://doi.org/10.1007/978-981-33-4497-6_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-4496-9
Online ISBN: 978-981-33-4497-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)